Enabling the next steps in cancer immunotherapy: from antibody-based bispecifics to multispecifics, with an evolving role for bioconjugation chemistry
Crossref DOI link: https://doi.org/10.1039/D1CB00082A
Published Online: 2022
Update policy: https://doi.org/10.1039/rsc_crossmark_policy
Thoreau, Fabien
Chudasama, Vijay https://orcid.org/0000-0002-8876-3285
Funding for this research was provided by:
European Commission (838703)
Version of Record valid from 2021-10-22
